rs368468
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_000089.4(COL1A2):c.808G>A(p.Val270Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00274 in 1,614,122 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000089.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL1A2 | NM_000089.4 | c.808G>A | p.Val270Ile | missense_variant | Exon 17 of 52 | ENST00000297268.11 | NP_000080.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00168 AC: 256AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00127 AC: 319AN: 251474Hom.: 0 AF XY: 0.00127 AC XY: 173AN XY: 135914
GnomAD4 exome AF: 0.00285 AC: 4163AN: 1461830Hom.: 7 Cov.: 32 AF XY: 0.00272 AC XY: 1980AN XY: 727214
GnomAD4 genome AF: 0.00168 AC: 256AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.00130 AC XY: 97AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:5
- -
Occurs in the triple helical domain at the {X/Y} position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the {X/Y} position is not a common mechanism of disease (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 27056980) -
- -
- -
COL1A2: BS1 -
not specified Benign:3
- -
- -
- -
Osteogenesis imperfecta Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Ehlers-Danlos syndrome Benign:1
- -
Ehlers-danlos syndrome, arthrochalasia type, 2 Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Osteogenesis imperfecta type I;C0268335:Ehlers-Danlos syndrome, classic type, 1 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Connective tissue disorder Benign:1
- -
Osteogenesis imperfecta, perinatal lethal;C0268363:Osteogenesis imperfecta with normal sclerae, dominant form;C4303789:Ehlers-Danlos syndrome, cardiac valvular type;C5436847:Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2;CN293783:Ehlers-danlos syndrome, arthrochalasia type, 2 Other:1
Variant classified as Uncertain significance and reported on 11-09-2018 by Baylor Genetics. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at